Diagnosis of histoplasmosis in urine cytology: Reactive urothelial changes, a diagnostic pitfall. Case report and literature review of urinary tract infections

2002 ◽  
Vol 26 (4) ◽  
pp. 243-246 ◽  
Author(s):  
Perkins Mukunyadzi ◽  
Michael Johnson ◽  
Joseph G. Wyble ◽  
Margie Scott
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Literature Review ◽  
Urinary Tract Infections ◽  
Urine Cytology ◽  
Diagnostic Pitfall ◽  
Tract Infections

scholarly journals Staphylococcus saprophyticus Bacteremia originating from Urinary Tract Infections: A Case Report and Literature Review

2016 ◽  
Vol 48 (2) ◽  
pp. 136 ◽  
Author(s):  
Jaehyung Hur ◽  
Anna Lee ◽  
Jeongmin Hong ◽  
Won-yong Jo ◽  
Oh-Hyun Cho ◽  
...  
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Literature Review ◽  
Urinary Tract Infections ◽  
Staphylococcus Saprophyticus ◽  
Tract Infections

scholarly journals Prevention of post coital cystitis: the role of D-mannose. Case report

2021 ◽  
pp. 590-593
Author(s):  
Anton Iu. Tsukanov ◽  
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Lower Urinary Tract ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Tract Infections ◽  
Recurrent Cystitis ◽  
Lower Urinary

Recurrent lower urinary tract infections are common among women. One of the important factors of their genesis is sexual activity: there is a positive correlation between sexual intercourse frequency and recurrences of lower urinary tract infections. Post coital cystitis accounts for 30–40% of all chronic recurrent cystitis and occurs in about 25–30% of women of reproductive age. One of the methods for the prevention of post coital cystitis is the use of D-mannose, the effectiveness of which was demonstrated with a clinical example.

scholarly journals Case Report: Primary squamous cell carcinoma of the bladder secondary to chronic renal fungal ball and recurrent polymicrobial urinary tract infections.

F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 84 ◽  
Author(s):  
Andrew Keller ◽  
Benjamin Shepherd ◽  
Arief Mulyadi ◽  
Ahmad Ali
Keyword(s):  
Squamous Cell Carcinoma ◽  
Case Report ◽  
Urinary Tract ◽  
Cell Carcinoma ◽  
Urinary Tract Infections ◽  
Squamous Cell ◽  
Renal Pelvis ◽  
Spinal Cord Injuries ◽  
Fungal Ball ◽  
Tract Infections

IntroductionSquamous cell carcinoma (SCC) of the bladder is a rare malignancy in Western countries accounting for only 5% of all primary bladder cancers. Chronic irritation is the predominant risk factor, with chronic infections, bladder stones and long term catheterisation common precursors. The highest incidence of SCC occurs in patients with spinal cord injuries who rely on indwelling or self-catheterisation for bladder drainage. We report a case of primary SCC of the bladder secondary to a fungal ball located in the renal pelvis.Case reportA 72 year-old lady was referred to our unit for further investigation of recurrent polymicrobial urinary tract infections associated with intermittent flank pain and complicated by sepsis. Investigations into the cause for her recurrent urinary tract infections identified a mass in her left renal pelvis. Pyeloscopy demonstrated no tumour, but a fungal ball. Attempts to clear the fungal ball via pyeloscopy resulted in recurrent intensive care unit (ICU) admission for urosepsis. Several months after her last pyeloscopy she returned with haematuria. Cystoscopy at this time revealed a large bladder mass. Biopsy revealed primary SCC of the bladder invading muscle. At cystectomy the mass had invaded pubic bone and was unresectable and a palliative ileal conduit was formed. The patient passed away less than 4 months following diagnosis.ConclusionWe report what we believe to be the first case of primary SCC of the bladder secondary to a renal pelvis fungal ball. Despite frequent surveillance of her urinary tract the tumour developed rapidly and was unresectable at diagnosis.

scholarly journals Raoultella Ornithinolytica Urinary Tract Infections are on the Rise: A Case Report

2018 ◽  
Vol 6 (6) ◽  
pp. 1-4
Author(s):  
Atif A. Katib ◽  
Bassem A. Dakkak ◽  
Husam A. Katib ◽  
Sara K. Alem
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Tract Infections

scholarly journals Cedecea lapagei An Extremely Rare Uropathogen: A Case Report and Review of the Literature

2021 ◽  
Author(s):  
Abdikarim Hussein Mohamed ◽  
Hussein Ali Mohamud
Keyword(s):  
Renal Failure ◽  
Case Report ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Beta Lactam ◽  
Gram Negative ◽  
Beta Lactamases ◽  
Extended Spectrum ◽  
Extended Spectrum Beta Lactamases ◽  
Tract Infections

Abstract Background: Gram-negative enterobacteria are the most common cause of urinary tract infections. Cedecea is a new separate genus in the family enterobacteriaceae, and it is a very rare pathogen that was primarily found in the respiratory tract. Cedecea lapagei is a very rare pathogen of urinary tract infections. To the best of our knowledge, this is the first case report in the world reported in English literature. Case presentation: A 55 years old man with chronic renal failure, poorly controlled diabetes mellitus, and hypertension presented with acute exacerbations of renal failure and irritative voiding symptoms. After stabilization and empirical antibiotic therapy with Ceftriaxone, the patient’s condition was not improved and deteriorated progressively. After the request of urine culture, the culture was isolated, an extremely rare uropathogen recently recognized by the Centers for Disease Control and Prevention (CDC); the Cedecea lapagei. Cedecea lapagei identification had been done using Eosin methylene blue agar (EMB). Gram-negative lipase positive bacteria with bacillus in shape, motile in nature that is non-spore-forming, and non-encapsulated enterobacteria with the final result of >100,000 colony-forming units per ml of Cedecea lapagei were isolated. Mueller-Hinton agar had been used to perform antimicrobial sensitivity and resistance. The pathogen was extensively resistant to the extended-spectrum beta-lactamases antibiotics and extended-spectrum beta-lactam inhibitors while carbapenems, fluoroquinolones, aminoglycosides, and Trimethoprim-sulfamethoxazole showed a higher sensitivity rate. Conclusion: The treatment of Cedecea lapagei infections represents a challenging issue due to its multi-drug resistant and extensive drug resistance patterns to a variety of antimicrobial classes, such as extended-spectrum beta-lactamases, cephalosporins, and beta-lactam inhibitors. Antimicrobial treatment should be aligned with the culture findings once available.

scholarly journals Hypercalciuria caused by CYP24A1 mutation as the cause of recurrent urinary tract infections – a case report

2019 ◽  
Vol 15 (4) ◽  
pp. 403-406
Author(s):  
Elżbieta Kuźma-Mroczkowska ◽  
◽  
Agata Poźniak ◽  
Karol Stachowicz ◽  
Hanna Szymanik-Grzelak ◽  
...  
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Recurrent Urinary Tract Infections ◽  
Tract Infections

scholarly journals Use of Intravesicular Amikacin Irrigations for the Treatment and Prophylaxis of Urinary Tract Infections in a Patient with Spina Bifida and Neurogenic Bladder: A Case Report

2011 ◽  
Vol 16 (2) ◽  
pp. 102-107
Author(s):  
Donna Huynh ◽  
Jill A. Morgan
Keyword(s):  
Case Report ◽  
Urinary Tract ◽  
Spina Bifida ◽  
Neurogenic Bladder ◽  
Urinary Tract Infections ◽  
Multidrug Resistant ◽  
Multiple Drug ◽  
Once Daily ◽  
Multiple Drug Resistant ◽  
Tract Infections

ABSTRACT This case report describes the use of intravesicular amikacin irrigations to treat and prevent urinary tract infections (UTIs) in a pediatric patient with spina bifida and neurogenic bladder. A 15 year old Hispanic female was admitted for a UTI caused by Enterobacter cloacae and multiple-drug resistant Pseudomonas aeruginosa. A 7 day course of daily intravenous amikacin and ceftazidime was initiated along with twice daily intravesicular amikacin irrigations (15 mg/30 mL) with a dwell time of 2 hours. The patient improved and was discharged on prophylactic Bactrim SS (sulfamethoxazole/trimethoprim) 1 tablet daily and intravesicular amikacin irrigations (15 mg/30 mL) once every other day. Approximately 2 months after discharge, the patient developed another UTI from multidrug resistant Escherichia coli and was treated with a 14 day course of daily intravenous ciprofloxacin accompanied by daily intravesicular amikacin irrigations. Adjunctive therapy with either once daily or twice daily intravesicular amikacin irrigations successfully treated the patient's UTI. However, prophylactic treatment with intravesicular amikacin failed to prevent future UTIs in this patient.

Sign in / Sign up

Export Citation Format

Share Document